China Universal Asset Management Company’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $131K | Sell |
5,901
-250
| -4% | -$5.55K | 0.01% | 342 |
|
2025
Q1 | $114K | Sell |
6,151
-301
| -5% | -$5.6K | 0.01% | 352 |
|
2024
Q4 | $85.4K | Buy |
6,452
+644
| +11% | +$8.53K | 0.01% | 411 |
|
2024
Q3 | $195K | Buy |
5,808
+2,600
| +81% | +$87.1K | 0.02% | 305 |
|
2024
Q2 | $80.4K | Sell |
3,208
-1,915
| -37% | -$48K | 0.01% | 314 |
|
2024
Q1 | $115K | Buy |
5,123
+2,051
| +67% | +$46.2K | 0.01% | 359 |
|
2023
Q4 | $65.8K | Buy |
3,072
+2,390
| +350% | +$51.2K | 0.01% | 337 |
|
2023
Q3 | $12.2K | Buy |
682
+335
| +97% | +$6.02K | ﹤0.01% | 336 |
|
2023
Q2 | $7.06K | Sell |
347
-38
| -10% | -$773 | ﹤0.01% | 339 |
|
2023
Q1 | $8.38K | Buy |
385
+96
| +33% | +$2.09K | ﹤0.01% | 317 |
|
2022
Q4 | $8.96K | Buy |
289
+24
| +9% | +$744 | ﹤0.01% | 237 |
|
2022
Q3 | $7K | Buy |
+265
| New | +$7K | ﹤0.01% | 231 |
|